EverSource Wealth Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

EverSource Wealth Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$685	Sell	73 -135	-65%	-$1.28K	﹤0.01%	4070
2026 Q1	$1.95K	Sell	208 -5	-2%	-$42	﹤0.01%	3651
2025 Q4	$1.73K	Sell	213 -15	-7%	-$185	﹤0.01%	3544
2025 Q3	$2.88K	Sell	228 -102	-31%	-$970	﹤0.01%	3394
2025 Q2	$2.28K	Buy	330 +230	+230%	+$1.67K	﹤0.01%	3466
2025 Q1	$531	Buy	100 +99	+9,900%	+$874	﹤0.01%	3438
2024 Q4	$12	Buy	+1	New	+$17	﹤0.01%	3729

Other funds holding CRBP

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

EverSource Wealth Advisors's CRBP Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Corbus Pharmaceuticals (CRBP) stake by 65% in Q2 2026, selling an estimated $1.28K and leaving 73 shares worth $685. The position accounts for ﹤0.01% of the portfolio, ranked #4070.

EverSource Wealth Advisors first reported a position in CRBP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.88K in Q3 2025. 22 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

EverSource Wealth Advisors held 73 shares of Corbus Pharmaceuticals worth $685 as of Q2 2026.
EverSource Wealth Advisors sold 135 Corbus Pharmaceuticals shares in Q2 2026, an estimated $1.28K.
Corbus Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4070 holding.
EverSource Wealth Advisors first reported a position in Corbus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
EverSource Wealth Advisors's Corbus Pharmaceuticals position peaked at $2.88K in Q3 2025.
22 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.